Back

Aspirin versus no aspirin on top of vitamin K antagonists in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischaemic and bleeding events

30 August 2016 (14:54 - 15:12)
Organised by:
Congress Presentation Part of: Tailoring antithrombotics according to bleeding risk Antithrombotic agents ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Gilles Lemesle

Lille University Hospital, Lille (France)

4 More presentations in this session

Presentation thumbnail
State of the art in tailoring antithrombotics according to bleeding risk.
Professor F. Andreotti (Rome, IT)
Presentation thumbnail
Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program
Professor M. Huisman (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Impact of previous exposure to oral anticoagulants on the risk of death or rehospitalization in patients with acute coronary syndrome - analysis according to the anticipated risk of bleeding.
Doctor C. Ruivo (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Future direction for research in tailoring according to bleeding risk.
Professor R. De Caterina (Pisa, IT)
Slides Video

Access the full session

Session thumbnail
Tailoring antithrombotics according to bleeding risk

The Event

Event poster

ESC Congress 2016

30 August 2016 14:54 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources